category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-2021,2.0635878013076783e-5,0.999999813425507,3,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-5788,2.0635878013076783e-5,0.999999813425507,3,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-6219,2.0635878013076783e-5,0.999999813425507,3,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-1782,1.043173100233228e-4,0.999998205815222,3,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-6303,3.568521984518668e-4,0.9999979799251043,2,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY0A-6303,0.0044758852809536785,0.99987990079962,2,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6443,0.00890226138615448,0.9991895148239059,3,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6890,0.009811464700778656,0.9999767841360304,1,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-5936,0.013912243868997068,0.9992822476051403,2,26,xyloglucan biosynthesis,BioCyc
ARA:PWY3DJ-35471,0.024794181228267827,0.999776337966301,1,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY-1081,0.0256811588645135,0.9981317872693043,2,38,homogalacturonan degradation,BioCyc
ARA:HOMOSERSYN-PWY,0.03895659970486395,0.9993346217728117,1,10,L-homoserine biosynthesis,BioCyc
ARA:PWY-6673,0.05797153197954936,0.9985334413626065,1,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6773,0.06058593431028309,0.9982931577280714,1,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,0.06961753145994123,0.9978101731967214,1,12,ethanol degradation I,BioCyc
ARA:PWY-6333,0.06961753145994123,0.9978101731967214,1,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-1001,0.07332007557767047,0.9974812447845035,1,20,cellulose biosynthesis,BioCyc
ARA:PWY-6546,0.07526210757287718,0.9975108223314235,1,9,brassinosteroids inactivation,BioCyc
ARA:PWY-5340,0.07820100764046498,0.9972766283878034,1,10,sulfate activation for sulfonation,BioCyc
ARA:GLYOXYLATE-BYPASS,0.09335968127846657,0.9959215378143073,1,17,glyoxylate cycle,BioCyc
ARA:PWY-5486,0.09358437230618354,0.9959170238600394,1,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-6040,0.09466581230732564,0.9959103029035397,1,12,chlorogenic acid biosynthesis II,BioCyc
ARA:TYRFUMCAT-PWY,0.09662089274564947,0.9956827054036289,1,14,L-tyrosine degradation I,BioCyc
ARA:PWY-5097,0.09817187324237604,0.9954529927949312,1,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5120,0.1340972140712099,0.9915573182669839,1,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:THRESYN-PWY,0.13445493083095994,0.9912000252236424,1,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:PWY-5122,0.1391356622170001,0.990808786313966,1,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWYQT-4449,0.14299466162049404,0.990276561926772,1,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWY66-21,0.15225943008847417,0.988564575281845,1,34,ethanol degradation II,BioCyc
ARA:PWY-6039,0.1559155397906057,0.988204120265968,1,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-5123,0.16173782714040197,0.9872764998349856,1,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-3801,0.1803696552275834,0.9836910289039016,1,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-5868,0.1840227810846751,0.9831826481448198,1,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-3001,0.18811897727151708,0.982203504525175,1,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-724,0.20533496321253178,0.9786465020330284,1,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-5121,0.2306180548546686,0.9729057626036657,1,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5992,0.26330451913468045,0.9639939350230526,1,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-361,0.3214758182136458,0.9446543427240529,1,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-101,0.37827010452002774,0.9215219681220183,1,46,photosynthesis light reactions,BioCyc
ARA:LIPAS-PWY,0.44634416983975495,0.885911710915954,1,93,triacylglycerol degradation,BioCyc
ARA:PHOTOALL-PWY,0.5419134093227129,0.8229748142342062,1,85,oxygenic photosynthesis,BioCyc
ARA:PWY-6842,0.9999999999999996,0.4797260604954631,0,71,glutathione-mediated detoxification II,BioCyc
ARA:ALACAT2-PWY,1,0.9336744253453613,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.9590262091225511,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.9590262091225511,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9707385593611,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.984294986060168,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.9851115469643408,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.9661133092267475,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.9180840117334478,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.9014870122284585,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.9076048038765389,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9758528977533073,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.9513448048829004,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9758528977533073,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.9369073253440499,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.9369073253440499,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.8695871358282318,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.9370990694933253,0,10,cyanide detoxification I,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,1,0.8141361937563195,0,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.9119437995992076,0,12,spermidine biosynthesis I,BioCyc
ARA:CALVIN-PWY,1,0.7410629188870165,0,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:CAMALEXIN-SYN,1,0.7987456966341083,0,29,camalexin biosynthesis,BioCyc
ARA:CHLOROPHYLL-SYN,1,0.8534775918943025,0,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:CITRULBIO-PWY,1,0.8292404867316815,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.992201320352639,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.9219168979112281,0,9,coenzyme A biosynthesis I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1,0.7794777502085269,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:CYANCAT-PWY,1,0.9732040980665578,0,3,cyanate degradation,BioCyc
ARA:CYSTSYN-PWY,1,0.8388565604805479,0,25,L-cysteine biosynthesis I,BioCyc
ARA:DETOX1-PWY,1,0.8755843474311213,0,21,superoxide radicals degradation,BioCyc
ARA:DETOX1-PWY-1,1,0.8154682327846438,0,28,reactive oxygen species degradation,BioCyc
ARA:FASYN-ELONG-PWY,1,0.8818344924463716,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.9431476847378033,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCONEO-PWY,1,0.6947312476643832,0,60,gluconeogenesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.9176378655220261,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9906596502532952,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9856527215057708,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.9736087588254029,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.9736087588254029,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.8626462983768763,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9882004038359633,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.9270607456380866,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.9669260384414557,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.8942504835557905,0,17,glycine cleavage,BioCyc
ARA:GLYCOLYSIS,1,0.7110514102808743,0,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:GLYOXDEG-PWY,1,0.9914109029189645,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYSYN-ALA-PWY,1,0.9379167200499708,0,12,glycine biosynthesis III,BioCyc
ARA:GLYSYN-PWY,1,0.9424801566049645,0,11,glycine biosynthesis I,BioCyc
ARA:GLYSYN2-PWY,1,0.8992686336715027,0,20,glycine biosynthesis,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.9222723753393145,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9868754715586545,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.9057148720334167,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9934531252152956,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9615394752377902,0,4,L-threonine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.9171349689467191,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,1,0.8850472164033127,0,20,L-isoleucine degradation I,BioCyc
ARA:ILEUSYN-PWY,1,0.9428070681577175,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.9890695722288703,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9913613678513415,0,1,L-cysteine degradation II,BioCyc
ARA:LEU-DEG2-PWY,1,0.8296916489570956,0,32,L-leucine degradation I,BioCyc
ARA:LEUSYN-PWY,1,0.8499076613134752,0,27,L-leucine biosynthesis,BioCyc
ARA:LIPASYN-PWY,1,0.6316688040519796,0,72,phospholipases,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.9435701843160669,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.8914185708921162,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9731976488116448,0,4,D-mannose degradation,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,1,0.8451543782206202,0,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.9325176802609574,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.9195188638390516,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.9147590244275764,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.8911336879911611,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:OXIDATIVEPENT-PWY,1,0.871279697124691,0,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:P401-PWY,1,0.9420387972236469,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.9569238076523824,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PENTOSE-P-PWY,1,0.7759311926600638,0,36,pentose phosphate pathway,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9665351460857513,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PLPSAL-PWY,1,0.9742983894778235,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9827858975215066,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9792646567627249,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9808343540953124,0,4,L-proline degradation,BioCyc
ARA:PWY-102,1,0.9400610137986951,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1042,1,0.7250241761913095,0,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-1061,1,0.829144452855399,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-112,1,0.9728034441955399,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-1121,1,0.6980220019999082,0,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-116,1,0.9718519259394311,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.9565644975226857,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.7719492797191919,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.9511596636446881,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.939451494978774,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.9525949636531246,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.9450640107178437,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1801,1,0.9861214933631797,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-181,1,0.7900340238721372,0,36,photorespiration,BioCyc
ARA:PWY-1822,1,0.9477802717925131,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9946388683940149,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9869152831735278,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2161,1,0.9227513914539562,0,16,folate polyglutamylation,BioCyc
ARA:PWY-2161B,1,0.9632628826352895,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.9475806037291719,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2181,1,0.9617152267630104,0,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:PWY-2261,1,0.8099182356791618,0,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-2301,1,0.9645676780570647,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.9381405393449769,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2541,1,0.759540291838357,0,44,plant sterol biosynthesis,BioCyc
ARA:PWY-2582,1,0.9603379742877086,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.9879800470914613,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.8870085746976764,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.9497735940970197,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9907167671097036,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.9401673892877414,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2821,1,0.8562142810797934,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.9670206529645101,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.9428354385292281,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.9428354385292281,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-2902,1,0.9429827616736988,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3041,1,0.9780376849806388,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.9084372549506516,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.9829556302981881,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-321,1,0.7933644373038509,0,35,cutin biosynthesis,BioCyc
ARA:PWY-3221,1,0.9910842634186967,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.9760188300741108,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.7958190431127096,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.9751091475356587,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.9272346779924329,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.9401938231979838,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.9138601884840409,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.8924349968482719,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.8966753844175638,0,26,choline biosynthesis III,BioCyc
ARA:PWY-3742,1,0.8198431213337456,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3781,1,0.3787109440050121,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWY-381,1,0.9298972707060422,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.9549590230556227,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3841,1,0.7960320828103231,0,38,folate transformations II,BioCyc
ARA:PWY-3881,1,0.9531705333318572,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3941,1,0.9648651092840764,0,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-3982,1,0.9821230815422098,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9886428301579169,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.9851115469643408,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.958724818359628,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.9323404634683635,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.8881619486885839,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.884339273428306,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.975553582726484,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.8820776645011447,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9892356651395673,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.9661925357218365,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.4513684382601188,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4321,1,0.9374527612230021,0,12,L-glutamate degradation IV,BioCyc
ARA:PWY-4341,1,0.9938035307921174,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.8691610937601116,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.9261072231152058,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.9309664729517623,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.9031595772769726,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.9231585554959586,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.97548414208491,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.9031595772769726,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.8968673321692491,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.9543788793945182,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.9510490832218709,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.9721499854935728,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.9647786952098261,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.9634717898434495,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9963793509431946,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.9795123721057846,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.8930396375390979,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.9816624697811699,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.9124679810106721,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.9037733309837308,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.9019565008923768,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5049,1,0.990127165641028,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.9696318577212176,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5063,1,0.9927364576984244,0,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-5064,1,0.9883325149893984,0,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5068,1,0.9705839369265977,0,6,chlorophyll cycle,BioCyc
ARA:PWY-5070,1,0.9215634068722989,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5079,1,0.9513705398009074,0,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5080,1,0.7489265138854309,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5083,1,0.5257095917297203,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5084,1,0.9184861174299377,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5086,1,0.995565127616572,0,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5098,1,0.9479950045213053,0,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5107,1,0.9839720139612499,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.9608702435694139,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9896769327799176,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.7847408504879941,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9950120221513814,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5125,1,0.9365225896770717,0,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5129,1,0.8227141100569517,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5136,1,0.9238321219544433,0,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-5138,1,0.9233294522547125,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.9595855354583939,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.9181291044617929,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.8443266379844065,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.9286219497786591,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.921462215304691,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5168,1,0.9745693503549047,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.9627386402773412,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9951227716502395,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.996015716109475,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.9239464835161738,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5194,1,0.9655469696571906,0,5,siroheme biosynthesis,BioCyc
ARA:PWY-5203,1,0.9478737050185726,0,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5267,1,0.9385861206123444,0,9,glucosinolate activation,BioCyc
ARA:PWY-5269,1,0.9512696478175293,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5271,1,0.9879790141094512,0,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-5272,1,0.9187883058657104,0,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5285,1,0.984157959306035,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.9919477655508299,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9633828394503641,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5320,1,0.8731799431963265,0,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5321,1,0.6685529979511934,0,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5326,1,0.9860847911295445,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5337,1,0.9309101429754589,0,12,stachyose biosynthesis,BioCyc
ARA:PWY-5342,1,0.9962848679526679,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5343,1,0.9954109297134139,0,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-5350,1,0.9093136613652517,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.9595855354583939,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.9762367389687482,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.726581024635215,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5386,1,0.8786682576731965,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.9703174212224672,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.9260101291436388,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.9413937249178211,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.973647646616542,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5453,1,0.882021124511422,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.9790793420561688,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9809958391276072,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9898879961684162,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5484,1,0.6731162745087631,0,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:PWY-5530,1,0.9489726397599326,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.7894172494054164,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.9898089356531289,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.9005675361234993,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.9395464352270992,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5667,1,0.8669668378219418,0,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-5669,1,0.979754617987366,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5670,1,0.9690155257809673,0,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-5686,1,0.9680955461157144,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5687,1,0.7825809854338313,0,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-5690,1,0.7429271336501967,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.9742668152713644,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9907209536973277,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9910743590856518,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9823666519222802,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9964928438866916,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.7620144579378733,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.9744581336934379,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9868754715586545,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5791,1,0.9407203331223135,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5800,1,0.9178713889790193,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9868754715586545,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-5807,1,0.9565897428237848,0,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-581,1,0.8131234193000237,0,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWY-5837,1,0.9407203331223135,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-5859,1,0.8996551364364339,0,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5871,1,0.9616351445289169,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9874551138701517,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5884,1,0.8428195054614206,0,22,wax esters biosynthesis I,BioCyc
ARA:PWY-5886,1,0.9768994647484917,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9735737597722555,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.9417901335832617,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.9246503807767327,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5943,1,0.9913295974504104,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.992302757926344,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9762571478055673,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9951227716502395,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9805924574790655,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9666696873055881,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.9389594531085027,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.7505307638738853,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.8180215652102762,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5980,1,0.8056260202913155,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY-5986,1,0.983267437308911,0,2,ammonium transport,BioCyc
ARA:PWY-5989,1,0.7578953529507475,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5995,1,0.981874517123612,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9846486802489577,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9871814611641323,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.9927048507641262,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.9964869467448171,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9931909269129964,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.7807777940076566,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9675632854340848,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6014,1,0.9569311409884934,0,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6019,1,0.9736893617158546,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6051,1,0.9379244119885403,0,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:PWY-6064,1,0.9842547142069001,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.9888776520267841,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.9592980544540344,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.956926055960267,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.9523277084939108,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.9523277084939108,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9723453376820866,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9930425316842673,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.9696879362091734,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.9488116348036241,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.9488829494355181,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.9701048879701959,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9824610068321674,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.926785684864896,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-621,1,0.8452293720072441,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.977775194634285,0,6,cadmium transport I,BioCyc
ARA:PWY-622,1,0.8777438636183419,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9755033345149645,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.9905761777378148,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.9755033345149645,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.967063045607799,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6239,1,0.9924167304378758,0,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-6266,1,0.6685529979511934,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,1,0.6685529979511934,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6287,1,0.9724514817211071,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.9790004544535598,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.9433799484259755,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6304,1,0.9734276907327265,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9772975761421661,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.9370027278149597,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6348,1,0.7990427203818652,0,27,phosphate acquisition,BioCyc
ARA:PWY-6352,1,0.7600847091901305,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6363,1,0.8995698171069785,0,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY-6364,1,0.9523043037631915,0,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6367,1,0.9187273597685416,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9645885247548858,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9925368226966164,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-641,1,0.9721597912280484,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9801027445384124,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.9441701859926137,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.9516718772167391,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6444,1,0.9379773292034065,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.9004316193377742,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.9481531696012514,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.939066701625054,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.9889770899097146,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.9368689427277788,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.957908777873655,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.9383417204763903,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9869694650858324,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.978279504487289,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.9380799292805747,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.9889770899097146,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.9608960103995201,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.9481098027770717,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6545,1,0.7993108541793473,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6549,1,0.828705972407057,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.9031595772769726,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9714472787414188,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.983434762778478,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.895023868758066,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.977853101989738,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.9390557316597126,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.9243076806080363,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.9206080555014999,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.9310485051789056,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.9116328320229231,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.9413820176791201,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.9617003448117295,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9913383354490181,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.9733783823306089,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6624,1,0.9805645635775087,0,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6663,1,0.9097065319070947,0,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-6666,1,0.982954211619105,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6707,1,0.9960357997855064,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6710,1,0.9569311409884934,0,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6724,1,0.921712050891518,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.9654345883049943,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6733,1,0.7774180857778125,0,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-6736,1,0.9801845250490543,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.9540405945295062,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6754,1,0.930994407130205,0,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6756,1,0.9504603132615804,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6762,1,0.9805645635775087,0,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-6786,1,0.8736394619378366,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6787,1,0.7917241165969185,0,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6792,1,0.9050661869967188,0,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6799,1,0.9905207066180025,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.9888881547984437,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6803,1,0.6470311037177743,0,65,phosphatidylcholine acyl editing,BioCyc
ARA:PWY-6804,1,0.9711018932675328,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9840787132072585,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.8607439331666534,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.9266691533188641,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.9186758313081788,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6845,1,0.9826764304727604,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6898,1,0.929505647919221,0,8,thiamine salvage III,BioCyc
ARA:PWY-6902,1,0.856018465518987,0,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-6908,1,0.9054254497994529,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9906485447115978,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9944416635287919,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.9580679541742445,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6927,1,0.910851899805299,0,14,chlorophyll a degradation II,BioCyc
ARA:PWY-6930,1,0.9626721602391043,0,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6931,1,0.9966553808581373,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.9865052215363953,0,2,selenate reduction,BioCyc
ARA:PWY-6936,1,0.93166156122552235,0,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-6938,1,0.9895586346900875,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.9119865963884207,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.9105580484419622,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.896984860170305,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.9343177091789354,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6982,1,0.9160796005505003,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.9481098027770717,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9912705685471623,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.9016198239395525,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7036,1,0.8220523955708058,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7039,1,0.763747121727133,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.9515715524063986,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.9625533258742772,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.9621101834492917,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.9734426245451482,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9614018954979376,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9614018954979376,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9798980788188904,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.9758784333077233,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.9553085048071166,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9808461252279271,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.9838219572270112,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9847247240712367,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7176,1,0.8198179967847155,0,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7177,1,0.9297872616460261,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.9533695635508409,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.7775140653203019,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7185,1,0.8796270875205808,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7186,1,0.9063284133945506,0,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-7187,1,0.8294193950084476,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.9219391095235967,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7196,1,0.7448411273800929,0,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7197,1,0.8706929122491339,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.9240548963169102,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.8042149842216337,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7204,1,0.8918827163713777,0,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:PWY-7205,1,0.8726503428826204,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.935095853932651,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7208,1,0.7812909561105998,0,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-7211,1,0.6706249144652734,0,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7213,1,0.9611622083996525,0,7,wogonin metabolism,BioCyc
ARA:PWY-7219,1,0.6906732055196084,0,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7221,1,0.865570059204874,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.887497997297587,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.90257145851629506,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.90257145851629506,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.842582871669229,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-7250,1,0.991709756309129,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9633828394503641,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7270,1,0.736207335964527,0,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-7325,1,0.992770562312942,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.9511206953710507,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.9677332808060781,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.9660446230848672,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.8590510712033262,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.8907283677098865,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.8160366980602584,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7398,1,0.850296933039789,0,19,coumarins biosynthesis (engineered),BioCyc
ARA:PWY-7416,1,0.8245054505354604,0,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7432,1,0.9228510249829761,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.9768893899182435,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7450,1,0.8106588742513529,0,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-7468,1,0.9805645635775087,0,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWY-7528,1,0.8027352436795713,0,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWY-7560,1,0.9082620484649695,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9825153316513401,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.9327918260909951,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9705947084168263,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-7640,1,0.9879790141094512,0,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-782,1,0.9421583590055839,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9819154676747,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.9713520191763118,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9895831139558062,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9914837875034254,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.9790004544535598,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.90257145851629506,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-861,1,0.9337983930681241,0,8,dhurrin biosynthesis,BioCyc
ARA:PWY-882,1,0.8667488904832846,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.9053329398911302,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9818370964967581,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.9661415429012455,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.9567171978812201,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1313,1,0.9596996626874278,0,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY0-1319,1,0.9304153953508687,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9758528977533073,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.940679602202584,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9824610068321674,0,2,D-serine degradation,BioCyc
ARA:PWY0-162,1,0.7934565489991582,0,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY0-166,1,0.8145196859412667,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY0-461,1,0.9589246280871796,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.9437381987572535,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.9855847576319208,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.9534229001713542,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY1F-353,1,0.9848619032538647,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.9808704482679217,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9666515360483338,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,1,0.7786259694979886,0,33,flavonoid biosynthesis,BioCyc
ARA:PWY3O-450,1,0.9400005603549241,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9713004702981114,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9820163321709792,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9826380075848883,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.9895306781773633,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.9895306781773633,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.9315520125080861,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.948943036208237,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.948943036208237,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.8918908851740907,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.9304716573408042,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.8981706728521435,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY4FS-8,1,0.8209558088422262,0,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY66-399,1,0.668671248467671,0,62,gluconeogenesis III,BioCyc
ARA:PWY66-423,1,0.9586754195844495,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.951659287230965,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.9779110842580323,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9855498778780918,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9753186016781332,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9719629890534375,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9798500442851694,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.8970938905838926,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4450,1,0.9476142863909894,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4466,1,0.7560049162906536,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWYQT-4470,1,0.9847097144619261,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4471,1,0.6242302781780426,0,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWYQT-4472,1,0.827694647029514,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.827694647029514,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.827694647029514,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4475,1,0.7979911885070969,0,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWYQT-4476,1,0.9474675612228748,0,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWYQT-4477,1,0.8754238243615399,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.729706170842475,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.9442494913785983,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-62,1,0.8168761096901044,0,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWYQT-94,1,0.8827508472205289,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.959609233414004,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.8733833359591482,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.9142793126718752,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.9460854357200801,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.9588252303692474,0,6,L-serine biosynthesis,BioCyc
ARA:SUCSYN-PWY,1,0.7735207785291284,0,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:SULFMETII-PWY,1,0.9385551787816374,0,9,sulfate reduction II (assimilatory),BioCyc
ARA:THIOREDOX-PWY,1,0.8124470253094739,0,19,thioredoxin pathway,BioCyc
ARA:TRESYN-PWY,1,0.8835765551563605,0,28,trehalose biosynthesis I,BioCyc
ARA:TRIGLSYN-PWY,1,0.6715505261949954,0,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:TRPSYN-PWY,1,0.873966616854394,0,22,L-tryptophan biosynthesis,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.9468744945159349,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALDEG-PWY,1,0.8453495653508328,0,30,L-valine degradation I,BioCyc
ARA:VALSYN-PWY,1,0.9254394893312686,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9827674697207408,0,4,xylose degradation I,BioCyc
ARA:PWY-6964,1.0000000000000002,0.9372897806762926,0,12,ammonia assimilation cycle II,BioCyc
ARA:ETHYL-PWY,1.0000000000000018,0.8047611443035013,0,31,ethylene biosynthesis I (plants),BioCyc
ARA:PWY-6351,1.0000000000000022,0.7578234716692431,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
